Physician

Abdul Qadir, M.D.

According to 2025 Medicare claims, Abdul Qadir, M.D. (NPI: 1891705182) practices internal medicine in the Elgin, IL market, with the plurality of this provider's patient population coming from Kane, IL. This provider's primary affiliated billing organization is ABDUL QADIR, MD, P.C. (NPI: 1275715351; TIN: 061644875) and primary practice location at 60506-1464.

Qadir's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 151 traditional Medicare patients, billed 642 HCPCS/CPT codes, and received $44,335 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 11,601 prescription claims across 452 beneficiaries totaling $1,109,529 in drug costs, led by Ozempic (Semaglutide). DME data shows 255 claims. Open Payments data shows 169 records totaling $3,266. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $92,839 to $44,335. In contrast, Part D prescription costs have risen steadily, from $709,572 to $1,109,529. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	392	1,469	$92,839
2016	347	1,308	$78,915
2017	352	1,519	$90,810
2018	339	1,687	$95,466
2019	300	1,479	$84,895
2020	247	1,404	$76,335
2021	162	982	$66,271
2022	162	1,054	$67,362
2023	158	857	$53,713
2024	151	642	$44,335

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	442	11,488	$709,572
2016	416	12,248	$869,370
2017	424	11,579	$755,093
2018	463	12,141	$804,831
2019	451	12,625	$818,885
2020	426	10,168	$700,340
2021	395	8,402	$722,550
2022	403	9,371	$887,892
2023	457	10,161	$1,030,602
2024	452	11,601	$1,109,529

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	63	518	$14,427
2016	42	328	$10,756
2017	52	232	$5,596
2018	17	181	$4,163
2019	37	195	$12,131
2020	30	171	$12,925
2021	25	270	$9,107
2022	24	317	$11,789
2023	N/R	139	$8,444
2024	16	255	$11,460

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	41	48	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	95	331	$73
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	21	22	$66
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	32	150	$52
99439	Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month	27	48	$40

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	129	4,004	$120,687
Eliquis	Apixaban	249	4,665	$97,361
Jardiance	Empagliflozin	161	4,549	$88,633
Mounjaro	Tirzepatide	60	1,848	$68,990
Vraylar	Cariprazine Hcl	45	1,410	$67,588

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$4,004
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	16	83	$3,973
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	19	$1,101
K0002	Standard hemi (low seat) wheelchair	Y	N/R	23	$667
K0003	Lightweight wheelchair	Y	N/R	23	$604

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	169	$3,266	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abdul Qadir, M.D.?

Tedicare shows public-source Medicare data for Abdul Qadir, M.D. (NPI 1891705182), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Qadir, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdul Qadir, M.D.?

Abdul Qadir, M.D. is linked to ABDUL QADIR, MD, P.C. (billing NPI 1275715351) in the available physician profile data.

Does Abdul Qadir, M.D. have Open Payments data?

Abdul Qadir, M.D. has 169 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.